ALK and anaplastic large cell lymphoma: Pharmacological investigation of lobatin B revealed that this compound also inhibited the expression of NPM/ALK, and in addition, the expression of JunB and PDGF-Rβ, and attenuated proliferation of ALCL cells by arresting them in late M phase [22].